TASMAN PHARMA

Serial Number 87569014
Registration 6200747
700

Registration Progress

Application Filed
Aug 15, 2017
Under Examination
Oct 9, 2018
Approved for Publication
Aug 14, 2018
Published for Opposition
Aug 14, 2018
Registered
Nov 17, 2020

Trademark Image

TASMAN PHARMA

Basic Information

Serial Number
87569014
Registration Number
6200747
Filing Date
August 15, 2017
Registration Date
November 17, 2020
Published for Opposition
August 14, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 17, 2020
Registration
Registered
Classes
005

Rights Holder

Douglas Pharmaceuticals Limited

03
Address
Central Park Drive, Lincoln
Auckland 0610
NZ

Ownership History

Douglas Pharmaceuticals Limited

Original Applicant
03
Auckland NZ

Douglas Pharmaceuticals Limited

Owner at Publication
03
Auckland NZ

Douglas Pharmaceuticals Limited

Original Registrant
03
Auckland NZ

Legal Representation

Attorney
Christopher D. Olszyk, Jr.

USPTO Deadlines

Next Deadline
473 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-11-17)
Due Date
November 17, 2026
Grace Period Ends
May 17, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

35 events
Date Code Type Description Documents
Nov 17, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 13, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Oct 10, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 9, 2020 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 6, 2020 IUAF S USE AMENDMENT FILED Loading...
Oct 6, 2020 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 8, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 6, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 6, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 6, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 16, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 15, 2019 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 15, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 9, 2019 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Oct 9, 2019 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 9, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 10, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 8, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 8, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 8, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 9, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 14, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 14, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 25, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 2, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 11, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 11, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 11, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 11, 2018 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 20, 2017 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 20, 2017 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 20, 2017 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 17, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 21, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 18, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders
First Use Anywhere: Oct 16, 2019
First Use in Commerce: Oct 16, 2019

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"